KMT2C and neoplasm: We recently reported functional evidence that shRNA-mediated knockdown of KMT2C or CREBBP in immortalized primary human keratinocytes was sufficient for cell transformation in vitro but was insufficient to promote tumor growth in vivo, suggesting that cuSCC development requires additional cooperating oncogenic events [17].